Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Bone Metastases: Different Mechanisms of Action for a Novel Therapeutic Application?
Endocrine-Related Cancer - United Kingdom
doi 10.1677/erc.1.01185
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2006
Authors
Publisher
BioScientifica